Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients

Chronic hepatitis C (CHC) is strongly associated with risks of cardiovascular diseases. The impact of direct acting antiviral (DAA) therapy on central blood pressure remains unclear. This investigation evaluates changes in central blood pressure following DAA therapy. One hundred and two DAA-treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Pin-Nan, Chen, Ju-Yi, Chiu, Yen-Cheng, Chiu, Hung-Chih, Tsai, Liang-Miin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363767/
https://www.ncbi.nlm.nih.gov/pubmed/30723238
http://dx.doi.org/10.1038/s41598-018-37829-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363767/
https://www.ncbi.nlm.nih.gov/pubmed/30723238
http://dx.doi.org/10.1038/s41598-018-37829-4

Ejemplares similares